Time Left to Bid
No deadline
OpenOtherFederal
Basic information
- Reference number
- 120924-2026
- Issuing organization
- N/A
- Government level
- Federal
- Solicitation type
- Other
- Title
- Suministro de medicamento Axicabtagen Ciloleucel
- Source
- TED (EU)
- Source ID
- 120924-2026
Details
- Location
- ES111, European Union
Summary
Contrato para el suministro sucesivo del medicamento antineoplásico 'Axicabtagen Ciloleucel' para el Área Sanitaria da Coruña e Cee. Adjudicación directa a Gilead Sciences debido a derechos exclusivos.
Contract for successive supply of the antineoplastic medication 'Axicabtagen Ciloleucel' for the A Coruña e Cee Health Area. Direct award to Gilead Sciences due to exclusive rights.
Dates
- Publication
- 2026/02/20 12:00:00 AM UTC
- Closing date
- N/A
Estimated value
$71.9M EUR
How to bid
Classification
Normalized category
Other